Cannabis News


Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) announced the first successful harvest from one of Canada’s largest indoor facilities, located in Farnham, Quebec

Cannara Biotech Inc. (“Cannara” or the “Company”) (CSE:LOVE) (OTCQB:LOVFF) (FRA:8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, today announced the first successful harvest from one of Canada’s largest indoor facilities, located in Farnham, Quebec. This scale and location provides Cannara with unique competitive advantages.

“Our core principle from the beginning of this venture has been premium quality always wins,” said Barry Laxer, COO of Cannara Biotech (Quebec) Inc. “All the measures we are committed to, from seed genetics to growing conditions to packaging protocols are all aimed at producing the best possible finished product. That’s what retailers and their customers want.”

The first harvest will now be carefully cured on their original stems for 14 days, in vigilantly monitored rooms with ultra-precise humidity and temperatures. This crafted tradition results in visually attractive and high quality buds, with intact trichomes and preserved terpenes. Following today’s harvest, Cannara’s state-of-the-art facility with best-in-class lighting, temperature and humidity controls now swings into full production with two flowering rooms harvested each week.

To share in this historical event, a video highlighting the harvest will be posted on the Company’s website later today at 4:20 pm.

About Cannara Biotech Inc.
Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) has built one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Quebec. Leveraging Quebec’s low electricity costs, Cannara Biotech Inc.’s facility will produce premium-grade indoor cannabis and cannabis-derivative products for the Quebec and Canadian markets.

The CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding “Forward-Looking” Information

This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company’s current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Click here to connect with Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) for an Investor Presentation.




S&P 5003906.83-16.85


Heating Oil3.65+0.08
Natural Gas8.15-0.22